**REGISTERED COMPANY NUMBER: 01886866 (England and Wales) REGISTERED CHARITY NUMBER: 291982** **Report of the Trustees and** **Unaudited Financial Statements** **for the Year Ended 31 December 2025** **for** **SYMPOSIUM MAMMOGRAPHICUM** **SYMPOSIUM MAMMOGRAPHICUM** **Contents of the Financial Statements for the Year Ended 31 December 2025** **----- Start of picture text -----**
Page
Report of the Trustees 1 to 9
Independent Examiner's Report 10 to 11
Statement of Financial Activities 12
Balance Sheet 13 to 14
Notes to the Financial Statements 15 to 19
Detailed Statement of Financial Activities 20 to 21
**----- End of picture text -----**
**SYMPOSIUM MAMMOGRAPHICUM** **Report of the Trustees for the Year Ended 31 December 2025** The Trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2025. The Trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). ## **OBJECTIVES AND ACTIVITIES** ## **Objectives and aims** The charity's objectives and aims are to promote research and to disseminate knowledge about improvements in methods and techniques for the prevention, diagnosis, and treatment of breast disease - cancer and other disorders. Page 1 **Report of the Trustees for the Year Ended 31 December 2025** ## **SYMPOSIUM MAMMOGRAPHICUM** ## **OBJECTIVES AND ACTIVITIES** ## **Significant activities** ## **Conference** The charity's 22nd conference (symposium) took take place at the Bournemouth International Centre, Bournemouth from 9th to 11th July 2025. Whilst much of the planning took place in 2024, there was significant activity in 2025 in refining the conference programme, workshops and structuring the parallel sessions. The conference programme consisted of the usual keynote addresses and plenary sessions, along with parallel and proffered paper sessions and satellite symposia. There was an increased presence and choice of educational workshops compared to previous symposia, which were very well received and a wide range of poster topics. The conference was attended by over 650 delegates who welcomed the forum to meet in person. The plenary and other selected sessions were recorded so that delegates could access the presentations on line after the event. The Organising Committee for the 2025 event was chaired by Dr Sarah Vinnicombe and vice chair Dr Nisha Sharma, both Trustees. The Committee is made up of Trustees as well as invited members from a range of disciplines to complement the core team to enhance the conference programme. As with past conferences, Organising Committee and Trustees reviewed and reflected on the delegate feedback about the conference, to help begin to shape the next conference which is scheduled to take place in July 2027 at the Edinburgh International Conference Centre. ## **Working with other organisations** The charity, as part of its objective to widen the scope of the conference, continues to collaborate with the **Association of Breast Clinicians (ABC)** to help promote greater exchange of knowledge and debate within the conference. The ABC hosted its own ses sion and AGM, whilst contributing strongly to the overall programme. Although the key focus was for the Organising Committee to manage the conference in July 2025, Symposium Mammographicum (SympMamm) had or would have a presence at a range of other organisations' events. The charity continued to embed its relationship with the **Society of Radiologists in Training** (SRT). Training workshops, organised by Ms Samantha Smith, Trustee, were embedded into their programme in Manchester, 22-23 May 2025. The workshops were supported by Trustees Dr Marianna Telesca, Dr Patsy Whelehan and former Trustee Ms Zebby Rees. Several commercial suppliers kindly supported the workshops by providing ultrasound machines and disposables. SympMamm hosted a biopsy workshop at the annual **UKIO** conference in Liverpool, 2-4 June 2025. The organisation of the workshops was led by Ms Claire Borrelli with support from former Trustees, Ms Zebby Rees and Ms Sue Garnett, supporter, Ms Hannah Lewis and Trustee Dr Liz O'Flynn. Several commercial suppliers kindly supported these workshops by providi ng ultrasound machines and disposables. SympMamm will be represented (as a co-sponsor) at the **UK Interdisciplinary Breast Cancer Symposium (UKIBCS)** in Birmingham on 19-20 January 2026. Dr Vinnicombe, who is a Committee Member of UKIBCS will chair two sessions: 'Transforming breast cancer research and management with AI' and 'Towards personalisation of screening.' Page 2 **SYMPOSIUM MAMMOGRAPHICUM** **Report of the Trustees for the Year Ended 31 December 2025** ## **OBJECTIVES AND ACTIVITIES** ## **Volunteers** The charity receives support from a number of experts who have joined the COC, who provide additional expertise to develop the scientific programme for the biennial conference. The Trustees are grateful for the time and dedication that the additional COC members contribute, considerably enriching the conference programmes. We are also grateful for the support from former Trustees and colleagues across the radiographic network to help run practical workshops. ## **ACHIEVEMENTS AND PERFORMANCE** ## **Charitable activities** Symposium Mammographicum promotes an Award scheme of up to £2,500 per award for radiologists, radiographers or other members of the diagnostic breast team. These can consist either of an Educational Award - to take up a secondment at a recognised centre in the UK or overseas to study a particular aspect of breast imaging practice, or a Research Award - to undertake a small research project related to breast imaging. The aim of the Awards is to support work which will contribute to improvement in the practice of breast imaging in the UK. The charity also provides bursaries for applicants from outside the United Kingdom, which aim either to facilitate study by an observational clinical attachment in a specialist training centre in the United Kingdom over a period of one or two weeks, or to facilitate attendance at the Symposium Mammographicum conference. The bursary scheme is also now open to certain groups of people within the UK to apply for funding to attend the Symposium or undertake a clinical observation placement. Eligible groups include public/patient representatives, professionals looking to return to work within breast services after a career break, and students interested in entering the breast specialism within the radiography or radiology disciplines. The Trustees continued to review ways of promoting the Award and Bursary schemes via web-based directories and on the websites of supportive organisations which hold similar objectives to Symposium Mammographicum. This has included support from the Higher Education Institutes to help attract radiography students. Trustees received a number of bursary requests which were reviewed at their December 2024 Board meeting. Taking account of the financial constraints, the charity was able to award bursaries to three people to attend the conference in July 2025. These included Dr Summer Amer, Radiologist from West Bank, Palestine, Ms Jane Brooks, Radiographer, Australia and Ms Deborah Mizzi, Radiographer, Malta. Page 3 **SYMPOSIUM MAMMOGRAPHICUM** **Report of the Trustees for the Year Ended 31 December 2025** ## **FINANCIAL REVIEW** ## **Principal funding sources** The Charity's principal sources of funding are the registration fees, exhibitors' payments, and sponsorship of the symposia, all within the biennial conference. For the first time, SympMamm applied to take part in a national fundraising event called the BIG GIVE Christmas Challenge. The fundraising week took part between the 2 to the 9 December 2025. Although the campaign did not reach its fund raising match target (SympMamm would have been supported by the Julia Rausing Trust if the pledge target had been achieved), £1053 was raised.. These funds were very welcomed and will be used to support future bursaries and research awards. Trustees will assess the fundraising programme in 2026 with a view to broadening its approach to bring this exercise to SympMamm's wider network, which is due to take place in December 2026. ## **Investment policy and objectives** The Trustees regularly monitor the return on the savings accounts, noting the interest rates and potential access to the reserves, and take a balanced approach given the degree of risk in arranging conferences. Following the Trustees' considered review of investments from mid-2015 to late 2016, with guidance from investment advisors (Sanlam), it was decided to maintain the current investment profile, with the caveat that regular benchmarking studies to compare interest rates would be undertaken to maximise the return. Such a review was undertaken in 2017 from which Trustees supported the transfer of funds from the then current saving facilities to different banks which offered more attractive interest rates. This exercise was completed in autumn 2017. Performance would be subject to review to ensure that the charity was able to secure a competitive return on investment, balanced against risk and accessibility of its reserves. This aspect is considered by the Trustees at each Board meeting, as part of the incorporation of the longer-term financial view as a standing item. In September 2024, Trustees agreed to open a second, interest-bearing, 40 day notice savings account to help maximise interest whilst retaining flexibility in managing the charity's reserves. This transfer took place in September 2024. ## **Reserves policy** The Trustees are conscious of the need to optimise the level of reserves the charity has at its disposal. In considering the level, attention has focused on the charity's operational needs, noting the significant up-front costs (and resultant potential risk) in setting up a conference. Regard was also paid to the perception of risk and the effects that external influences could have on income (for example, delegate numbers, exhibition size and income, venue costs, economic climate, reputation), mindful of the charity's objects and their continuing relevance. A summary review of the Reserves Policy was undertaken in 2017 and a detailed review was completed in 2021 to reflect the change in circumstances arising from the pandemic. A review of the policy, planned for 2025, will take place in spring 2026. ## **Financial Management** Trustees have a robust set of measures to provide greater clarity on the charity's standing and financial status, in tandem with the reserves policy and strategy. The measures include the adoption of longer-range forecasting over a two-year cycle at each meeting, to help provide assurance and highlight any risks from potential imbalances between income and expenditure, informed by experience from past cycles. In addition, to help minimise running costs to the charity, Trustees now alternate their quarterly meetings between meeting in person and using online video conferencing. Page 4 **SYMPOSIUM MAMMOGRAPHICUM** **Report of the Trustees for the Year Ended 31 December 2025** ## **FUTURE PLANS** ## **Strategic** Arrangements for the Edinburgh International Conference Centre in Edinburgh to host the 23nd Symposium Mammographicum conference from the 7th to 9th 2027 arein progress. An Organising Committee will be established in March 2026, Dr Nisha Sharma as its Chair. The Committee is made up of Trustees as well as invited experts from a range of disciplines to complement the core team and enhance the conference programme. The close collaboration with the Association of Breast Clinicians continues, with them organising their own sessions in parallel to the main SympMamm programme. The programme will also build on the multi-disciplinary element, and incorporate a physics training event, together with practical workshops. Plans continue to work with similar organisations to help raise the charity's profile. This will include having a presence at the Society of Radiologists in Training, Association of Breast Surgeons and UKIO conferences in 2026/07. ## **Membership / Supporters scheme** Trustees continued to review the current arrangements and considered a range of ways to encourage financial support for Symposium Mammographicum, which included options for setting up a supporters' network. The charity's website was updated with information about how people could support Symposium Mammographicum, establishing PayPal and JustGiving links to receive donations as well as describing ways to leave a legacy via a will. The Trustees are grateful for the continuing support from Members, (typically former Trustees) particularly with ongoing support for some of the collaborative work with other educational bodies such as the Society of Radiologists in Training. ## **Operational** Trustees appointed Profile Productions to organise the charity's 2027 conference in Edinburgh, following the success of the 2025 event in Bournemouth. The charity appointed Sandison Lang & Co to provide an independent examination of their annual report and accounts, with effect from 1 January 2025. This proposal was supported at the Annual General Meeting on the 17 September 2025. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity is a company limited by guarantee as defined by the Companies Act 2006 and is governed by its Memorandum and Articles of Association, updated and approved at the AGM in 2024, following a considered governance review. Page 5 **SYMPOSIUM MAMMOGRAPHICUM** **Report of the Trustees for the Year Ended 31 December 2025** ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Organisational structure** The charity's Trustees met four times in 2025, to manage its affairs, ensuring that its work is in line with its mission and aims, providing a strategic overview of the running of the conference and associated activities, finance and budget monitoring, investments, succession planning, and receiving and reviewing of award and bursary applications. Running consecutively, the Conference Organising Committee (COC) met four times, chaired by Trustee Dr Sarah Vinnicombe with fellow Trustee Dr Nisha Sharma as its Vice-Chair. The expertise of the Trustees is augmented on the COC by the appointment of: - Mrs Asmaa Al-Allak, Consultant Breast Surgeon, Cardiff and Vale University Health Board - Dr Monika Banerjee, Trainee Radiologist, Salisbury NHS Foundation Trust - Ms Lucy Cielecki, Consultant Radiographer in Breast Imaging, Shrewsbury and Telford Hospitals NHS Trust - Ms Noelle Clerkin, Deputy Breast Service Manager, Belfast Breast Unit - Ms Kaye Day, Mammography Assistant Practitioner, Shrewsbury and Telford Hospitals NHS Trust - Dr Elisabetta Giannotti, Consultant Breast Radiologist, Cambridge University Hospitals NHS Foundation Trust - Dr Zoe Goldthorpe, Associate Specialist Breast Clinician, Director, Somerset Breast Screening, Vice President, Association of Breast Clinicians - Ms Helen Taylor, Service Lead Breast Imaging, Superintendent Radiographer, Gloucestershire Hospitals NHS Foundation Trust. The COC for the 2025 conference will continue until the end of the organising cycle in September 2025 and will be superseded by a new COC in March 2026 to support the 2027 conference. In addition, the charity continued to work closely with the Association of Breast Clinicians, represented by Dr Cathy Coleman, who is also a Trustee of Symposium Mammographicum. Dr Coleman's role was succeeded by Dr Zoe Goldthorpe following the AGM in September 2025. The Symposium attracts members of the medical, nursing and allied health professions, and associated staff, nationally and internationally. Manufacturers of medical equipment are invited for the purpose of presenting their own expertise and information and learning from the like presentation of others. ## **Trustees** The constituency of the Board of Trustees changed in 2025, with five resignations and three appointments. In May, Ms Sarah MacKellar stood down after five year's service. At the Annual General Meeting on 17 September, Ms Anna Burch, Dr Cathy Coleman, Dr Claire Mercer and Dr Sarah Tennant resigned after a collective 26 years' enthusiastic service to the charity. In September, Ms Lucy Cielecki, Dr Zoe Goldthorpe and Ms Helen Taylor were appointed. All three appointees had served on the COC for the 2025 conference. Dr Patsy Whelehan stood down in her role of Co-Chair of Trustees in September but continues to play an active role as a Trustee. Mr Oliver Morrish, Co-Chair become the Chair of Trustees from September. Dr Michael Michell indicated his wish to stand down as President in the spring of 2025. This triggered a review and election process between the Trustees, which resulted in the selection of Ms Samantha Smith as President elect. Following the announcement at the Bournemouth Conference, Dr Michell stepped down from his role after 18 years valuable service and Ms Smith succeeded formally in this role at the AGM in September. Page 6 **Report of the Trustees for the Year Ended 31 December 2025** ## **SYMPOSIUM MAMMOGRAPHICUM** ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Risk management** The Trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. During the year, Trustees have continued to review risks by updating and refining the Risk Register, which has led to: - assessing contract risk - further reviewing the Reserves Policy - assessing the Investment Policy - reviewing safeguards against fraudulent activity by those with access to the charity's bank accounts - continuing regular monitoring of income, expenditure, and effective management of the biennial symposia. The Risk Register is reviewed formally on an annual basis and financial risks are considered at each meeting. ## **Fraud and Ethics Policy** Following a review of the Charity Commission's best practice guidance on Fraud, Anti Bribery and Ethics, the Charity continues to follow its policy, developed in 2017, which will be due for review in spring 2026 It is noted that Trustees and the Company Secretary already receive training and guidance regarding fraud, bribery, conflicts of interest and safeguarding by virtue of their professional roles in the National Health Service and Law Society. ## **Complaints Policy** Following a review of the Charity Commission's best practice guidance, a Complaints Policy was developed and agreed in March 2019. ## **Document Retention Policy** A policy to regularise documents managed and retained by the Secretary was established in June 2022, in terms of paper and electronic records, along with the appropriate measures for secure disposal of records falling outside the statutory / best practice retention periods. ## **Governance** As part of the review of its constitution, Trustees reviewed and adopted a range of policies during 2024 and 2025 to enhance good practice. These included: Fundraising, Anti-bullying, Grievance, Confidentiality, Conflicts of Interest, Safeguarding, Financial Controls and Whistle-blowing. In turn, all policies are reviewed on a regular basis to ensure they are fit for purpose. The Trustees advise that no events occurred in the year to meet the threshold to trigger any concerns In addition, role descriptions for Trustee, Chair, President, and Treasurer were formalised. ## **Legislation** The Trustees were mindful of potential changes to the data protection regulations (GDPR) and considered the changes in charity legislation under the Charities Act 2022. ## **REFERENCE AND ADMINISTRATIVE DETAILS** ## **Registered Company number** 01886866 (England and Wales) Page 7 ## **SYMPOSIUM MAMMOGRAPHICUM** ## **Report of the Trustees for the Year Ended 31 December 2025** **Registered Charity number** 291982 ## **Registered office** 2 St. Mary's Road Tonbridge Kent TN9 2LB ## **Trustees** **Trustees** Dr M J Michell President (until 17 September 2025) Dr P Whelehan Chair (co-chair until 17 September 2025) Ms C Bailey Mrs C Borrelli Ms A Burch retired 17 September 2025 Ms L Cielecki appointed 17 September 2025 Dr C Coleman retired 17 September 2025 Dr R Deb Dr R Given-Wilson Dr Z Goldthorpe appointed 17 September 2025 Prof M D Halling-Brown Prof N Healy Ms S McKellar retired 14 May 2025 Dr C Mercer retired 17 September 2025 Mr O W E Morrish Co-chair until 17 September 2025 and Chair from 17 September 2025 Dr E O'Flynn Mr D P L Ribet Dr N Sharma Ms S Smith President from 17 September 2025 Ms H Taylor appointed 17 September 2025 Dr M Telesca Dr S Tennant retired 17 September 2025 Dr S Vinnicombe ## **Company Secretary** Mr D P L Ribet ## **Independent Examiner** Mr Ryan Cottington ACA Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB Page 8 **Report of the Trustees for the Year Ended 31 December 2025** ## **SYMPOSIUM MAMMOGRAPHICUM** This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. Approved by order of the board of Trustees on ............................................. and signed on its behalf by: ................................................................... O W E Morrish - Trustee Page 9 **Independent Examiner's Report to the Trustees of Symposium Mammographicum** ## **Independent examiner's report to the trustees of Symposium Mammographicum ('the Company')** I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2025. ## **Responsibilities and basis of report** As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act. Page 10 **Independent Examiner's Report to the Trustees of Symposium Mammographicum** ## **Independent examiner's statement** Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)). I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Mr Ryan Cottington ACA Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB Date: ............................................. Page 11 ## **SYMPOSIUM MAMMOGRAPHICUM** ## **Statement of Financial Activities for the Year Ended 31 December 2025** |Notes
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
**Charitable activities**
Educational and academic
Investment income
2|**2025**
2024
**Unrestricted**
**funds**
Total funds
**£**
£
**1,183**
-
**304,870**
-
**4,136**
2,738| |---|---| |**Total**|**310,189**
2,738| |**EXPENDITURE ON**
**Charitable activities**
Educational and academic|**273,534**
16,505| |**NET INCOME/(EXPENDITURE)**
**RECONCILIATION OF FUNDS**
Total funds brought forward|**36,655**
(13,767)
**106,609**
120,376| |**TOTAL FUNDS CARRIED FORWARD**|**143,264**
106,609| The notes form part of these financial statements Page 12 **SYMPOSIUM MAMMOGRAPHICUM** ## **Balance Sheet 31 December 2025** |Notes
**CURRENT ASSETS**
Debtors
5
Cash at bank|**2025**
**Unrestricted**
**funds**
**£**
**8,306**
**138,908**|2024
Total funds
£
33,560
171,033| |---|---|---| |**CREDITORS**
Amounts falling due within one year
6|**147,214**
**(3,950)**|204,593
(97,984)| |**NET CURRENT ASSETS**|**143,264**|106,609| |**TOTAL ASSETS LESS CURRENT LIABILITIES**|**143,264**|106,609| |**NET ASSETS**|**143,264**|106,609| |**FUNDS**
7
Unrestricted funds|**143,264**|106,609| |**TOTAL FUNDS**|**143,264**|106,609| The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025. The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006. The trustees acknowledge their responsibilities for - (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and - (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. The notes form part of these financial statements continued... Page 13 ## **SYMPOSIUM MAMMOGRAPHICUM** ## **Balance Sheet - continued 31 December 2025** These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: ............................................. O W E Morrish - Trustee The notes form part of these financial statements Page 14 **SYMPOSIUM MAMMOGRAPHICUM** **Notes to the Financial Statements for the Year Ended 31 December 2025** ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. ## **Taxation** The charity is exempt from corporation tax on its charitable activities. ## **2. INVESTMENT INCOME** **----- Start of picture text -----**
|||| |---|---|---| |2025|2024| |£|£| |Deposit account interest|4,136|2,738| **----- End of picture text -----**
continued... Page 15 **SYMPOSIUM MAMMOGRAPHICUM** **Notes to the Financial Statements - continued for the Year Ended 31 December 2025** ## **3. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 31 December 2025 nor for the year ended 31 December 2024. ## **Trustees' expenses** Trustees expenses consist of the following: Travel expenditure for meetings - £1,584 ## **4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** |**INCOME AND ENDOWMENTS FROM**
Investment income|Unrestricted
funds
£
2,738| |---|---| |**EXPENDITURE ON**
**Charitable activities**
Educational and academic|16,505| |**NET INCOME/(EXPENDITURE)**
**RECONCILIATION OF FUNDS**
Total funds brought forward|(13,767)
120,376| |**TOTAL FUNDS CARRIED FORWARD**|106,609| continued... Page 16 **SYMPOSIUM MAMMOGRAPHICUM** **Notes to the Financial Statements - continued for the Year Ended 31 December 2025** **----- Start of picture text -----**
5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade debtors 5,466 -
VAT 2,415 -
Prepayments 425 33,560
8,306 33,560
6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
VAT - 12,385
Other creditors 3,950 3,800
Accruals and deferred income - 81,799
3,950 97,984
7. MOVEMENT IN FUNDS
Net
movement At
At 1/1/25 in funds 31/12/25
£ £ £
Unrestricted funds
General fund 106,609 36,655 143,264
TOTAL FUNDS 106,609 36,655 143,264
Net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 310,189 (273,534) 36,655
TOTAL FUNDS 310,189 (273,534) 36,655
**----- End of picture text -----**
continued... Page 17 **SYMPOSIUM MAMMOGRAPHICUM** **Notes to the Financial Statements - continued for the Year Ended 31 December 2025** ## **7. MOVEMENT IN FUNDS - continued** ## **Comparatives for movement in funds** |At 1/1/24
£
**Unrestricted funds**
General fund
120,376|Net
movement
in funds
£
(13,767)|At
31/12/24
£
106,609| |---|---|---| |**TOTAL FUNDS**
120,376|(13,767)|106,609| |Comparative net movement in funds, included in the above are as follows:
Incoming
resources
£
**Unrestricted funds**
General fund
2,738|Resources
expended
£
(16,505)|Movement
in funds
£
(13,767)| |**TOTAL FUNDS**
2,738|(16,505)|(13,767)| |A current year 12 months and prior year 12 months combined position is as
At 1/1/24
£
**Unrestricted funds**
General fund
120,376|follows:
Net
movement
in funds
£
22,888|At
31/12/25
£
143,264| |**TOTAL FUNDS**
120,376|22,888|143,264| continued... Page 18 **SYMPOSIUM MAMMOGRAPHICUM** **Notes to the Financial Statements - continued for the Year Ended 31 December 2025** ## **7. MOVEMENT IN FUNDS - continued** A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: |**Unrestricted funds**
General fund|Incoming
Resources
resources
expended
£
£
312,927
(290,039)|Movement
in funds
£
22,888| |---|---|---| |**TOTAL FUNDS**|312,927
(290,039)|22,888| ## **8. RELATED PARTY DISCLOSURES** There were no related party transactions for the year ended 31 December 2025. Page 19 ## **SYMPOSIUM MAMMOGRAPHICUM** ## **Detailed Statement of Financial Activities for the Year Ended 31 December 2025** |**INCOME AND ENDOWMENTS**
**Donations and legacies**
Gifts
Gift aid
**Investment income**
Deposit account interest
**Charitable activities**
Delegate sales
Sponsorship income
Exhibition fees
**Total incoming resources**
**EXPENDITURE**
**Charitable activities**
Venues & speakers
Symposium costs
Grants & awards to individuals
**Support costs**
**Management**
Advertising
Secretarial & administration
Travel
**Finance**
Bank charges|2025
£
**1,053**
**130**
**1,183**
**4,136**
**150,795**
**42,960**
**111,115**
**304,870**
**310,189**
**135,897**
**115,648**
**4,460**
**256,005**
**217**
**11,995**
**1,270**
**13,482**
**186**|2024
£
-
-
-
2,738
-
-
-
-
2,738
(4,500)
1,335
-
(3,165)
-
12,521
-
12,521
192| |---|---|---| This page does not form part of the statutory financial statements Page 20 ## **SYMPOSIUM MAMMOGRAPHICUM** ## **Detailed Statement of Financial Activities for the Year Ended 31 December 2025** |**Finance**
**Information technology**
Domain, website & email hosting
**Governance costs**
Trustees' expenses
Sundries
Accountancy and legal fees
Total resources expended
**Net income/(expenditure)**|2025
£
**390**
**1,586**
**88**
**1,797**
**3,471**
**273,534**
**36,655**|2024
£
620
1,005
1,820
3,512
6,337
16,505
(13,767)| |---|---|---| This page does not form part of the statutory financial statements Page 21